AB Science touts positive Phase II Covid-19 data for masitinib
AB Science has announced positive data from the Phase II trial investigating lead asset masitinib in hospitalised Covid-19 patients, highlighting…
AB Science has announced positive data from the Phase II trial investigating lead asset masitinib in hospitalised Covid-19 patients, highlighting…
The US National Institutes of Health (NIH) has announced the start of subject enrolment for a Phase I clinical trial…
CyanVac has received US federal funding through the Project NextGen initiative to conduct a Phase IIb comparative clinical trial of…
Moderna has announced that its Phase III clinical trial of the investigational next-generation Covid-19 vaccine, mRNA-1283, met its primary efficacy…
Health Canada has granted approval to Entos Pharmaceuticals to commence a Phase I/II clinical trial of its investigational Covid-19 vaccine…
A new article has been published in the journal Nature Sustainability highlighting that there is an urgent need to design…
AstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly AZD3152) met the primary endpoints in…
Allucent has received a $25.5m Biomedical Advanced Research and Development Authority (BARDA)-funded grant to support a Covid-19 vaccine decentralised clinical…
Moderna has announced positive interim results from the Phase III NextCOVE clinical trial, where its next-generation Covid-19 vaccine candidate, mRNA-1283,…
Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic…